Specialty code 183500000X · Oakland, CA
NPI
1104377126
Since 2016
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3801 Howe Street, Fabiola G-25
Oakland, CA, 94611
Phone (510) 752-1000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$617K
4,679 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Collin Chan prescribed most often to Medicare patients was Atorvastatin Calcium, with 854 prescriptions and refills. In total Collin Chan wrote 4,679 Medicare prescriptions that cost $617K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 854 | 2,835 | 327 | $11K |
| Metformin Hcl Er Metformin Hcl | 520 | 1,714 | 218 | $5,115 |
| Jardiance Empagliflozin | 414 | 1,343 | 166 | $246K |
| Metformin Hcl Generic | 399 | 1,330 | 158 | $5,203 |
| Lisinopril Generic | 334 | 1,100 | 124 | $4,140 |
| Losartan Potassium Generic | 292 | 973 | 106 | $4,011 |
| Glipizide Er Glipizide | 274 | 908 | 119 | $9,090 |
| Glipizide Generic | 219 | 724 | 94 | $3,523 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 162 | 457 | 63 | $54K |
| Simvastatin Generic | 161 | 537 | 60 | $1,896 |
| Ozempic Semaglutide | 160 | 167 | 35 | $118K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 89 | 283 | 50 | $2,673 |
| Rosuvastatin Calcium Generic | 74 | 247 | 29 | $870 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 60 | 176 | 22 | $16K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 52 | 164 | 23 | $1,734 |
Brand drugs: 1,038 claims; generic drugs: 3,388 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Collin Chan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.